SOX4 reversibly induces phenotypic changes by suppressing the epithelial marker genes in human keratinocytes

Mol Biol Rep. 2024 Jan 16;51(1):116. doi: 10.1007/s11033-023-09035-7.

Abstract

Background: SOX4 is a transcription factor belonging to the SOX (Sry-related High Mobility Group [HMG] box) family and plays a pivotal role in various biological processes at various stages of life. SOX4 is also expressed in the skin in adults and has been reported to be involved in wound healing, tumor formation, and metastasis.

Methods and results: In this study, we investigated the role of SOX4 in keratinocyte phenotypic changes. We generated a SOX4-overexpressing keratinocyte cell line that expresses SOX4 in a doxycycline (DOX)-inducible manner. DOX treatment induced a change from a paving stone-like morphology to a spindle-like morphology under microscopic observation. Comprehensive gene analysis by RNA sequencing revealed increased expression of genes related to anatomical morphogenesis and cell differentiation as well as decreased expression of genes related to epithelial formation and keratinization, suggesting that SOX4 induced EMT-like phenotype in keratinocytes. Differentially expressed genes (DEGs) obtained by RNA-seq were confirmed using qRT-PCR. DOX-treated TY-1 SOX4 showed a decrease in the epithelial markers (KRT15, KRT13, KRT5, and CLDN1) and an increase in the mesenchymal marker FN1. Protein expression changes by Western blotting also showed a decrease in the epithelial marker proteins keratin 15, keratin 13, and claudin 1, and an increase in the mesenchymal marker fibronectin. Removal of DOX from DOX-treated cells also restored the epithelial and mesenchymal markers altered by SOX4.

Conclusion: Our results indicate that SOX4 reversibly induces an EMT-like phenotype in human keratinocytes via suppression of epithelial marker genes.

Keywords: EMT; HaCaT; Keratinocyte; RNA-seq; SOX4.

MeSH terms

  • Blotting, Western
  • Doxycycline
  • Gene Expression
  • Humans
  • Keratinocytes*
  • Phenotype
  • SOXC Transcription Factors* / genetics
  • Skin*

Substances

  • Doxycycline
  • SOX4 protein, human
  • SOXC Transcription Factors